已收录 268921 条政策
 政策提纲
  • 暂无提纲
Determination and Method Validation for Metformin Hydrochloride Drug Content fromPharmaceutical Product by Reversed Phase High Performance Liquid Chromatography.
[摘要] Reversed phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of metformin hydrochloride from marketed tablets. Chromatographic Separation of metformin hydrochloride has been done with C18 column. The mobile phase methanol-water was used in the ratio 70:30 (v/v). The HPLC instrument was equipped with dual pump and UV-VIS detector. The active ingredient of the drug content metformin hydrochloride was optimized at 216 nm. Drug content was determined at the flow rate 1.0 mL/min. The retention time of analyte was 6.38 min. The linearity range was 5-100 μg/mL. The linearity of the method was obtained (R2=0.997). The limit of detection (LOD) and limit of quantification (LOQ) were calculated to be 0.03 and 0.09 μg/mL, respectively. The recoveries of the drug content were found at the three concentration level 99.80, 99.90 and 99.80 %, respectively. Hence, all these results shown that the method validation can be used for routine analysis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文